Testing SHAPE: A Single-Session Intervention Targeting Binge Eating in Women Through Assessment and Values-Based Strategies
SHAPE
Testing a Single-session Consultation for Reducing Binge Eating
1 other identifier
interventional
56
1 country
1
Brief Summary
The goal of this controlled trial is to learn whether a brief single-session intervention (SSI) can reduce binge eating symptoms by targeting overvaluation of weight/shape in women with recurrent binge eating. The main questions it aims to answer are:
- Does assessment alone reduce binge eating severity and overvaluation of weight/shape compared to a control group undergoing minimal assessment?
- Does adding a values-based reflection and goal-setting component (the full SHAPE intervention) add benefits beyond the assessment alone? Researchers will compare three groups:
- assessment-only,
- full SHAPE intervention, and
- minimal assessment control to see if both active conditions outperform the control, and whether the full intervention adds any benefits beyond the assessment itself
- Complete a semi-structured eating disorder assessment (Eating Disorder Examination)
- Depending on assignment, also complete a values-based reflection and goal-setting exercise with psychoeducation
- Complete follow-up assessments evaluating binge eating severity, overvaluation of weight/shape, clinical impairment, binge frequency, and related outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
October 14, 2025
CompletedFirst Posted
Study publicly available on registry
October 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
October 20, 2025
October 1, 2025
1 year
October 14, 2025
October 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in overvaluation of weight/shape
Changes in Shape/weight overvaluation subscale score on 7-Item Eating Disorder Examination Questionnaire
1 month
Change in binge eating severity
Change in scores on Binge Eating Scale
1 month
Secondary Outcomes (6)
Change in Body Image Flexibility
1 month
Change in eating self-efficacy
1 month
Change in readiness to change eating disorder symptoms
1 month
Change in eating disorder-related clinical impairment
1 month
Change in depressive symtpoms
1 month
- +1 more secondary outcomes
Study Arms (3)
Assessment-only
ACTIVE COMPARATORDiagnostic items of the Eating Disorder Examindation (EDE)
Full Intervention (SHAPE)
ACTIVE COMPARATORDiagnostic items of the Eating Disorder Examindation (EDE) \+ Values-based reflection and goal-setting exercises
Minimal-Assessment Control
PLACEBO COMPARATORIntro/Eating Pattern + Bulimic Episodes/Overeating Sections of Eating Disorder Examindation (EDE)
Interventions
Diagnostic items of the Eating Disorder Examindation (EDE)
Assessment-only intervention + values-based reflection and goal-setting/action-planning exercises
Invovles completing only the Intro/Eating Pattern + Bulimic Episodes/Overeating Sections of Eating Disorder Examination (EDE)
Eligibility Criteria
You may qualify if:
- ≥ 18 years old
- Identify as cisgender female
- self-reported BMI ≥ 18.5 kg/m²
- Rate the extent to which their weight or shape influences how they feel about themselves as a "4" or higher on a 7-point Likert scale on screening measures
- ≥1 binge eating episode every 2 weeks (i.e., ≥ six episodes over 3 months) at the time of screening
You may not qualify if:
- \< 18 years old
- Assigned male at birth
- Gender identity different from biological sex indicated on birth certificate
- Purging behaviors (i.e., self-induced vomiting, laxative misuse, or diuretic misuse) ≥ 1x/week in the last 3 months at the time of screening.
- Engaged in structured psychological therapy or counseling (defined as attending sessions \> 1x/month in the past 3 months)
- Prior participation in studies that include administration of the EDE interview at Ohio University (IRB-FY24-403, IRB-FY25-330, and IRB-21-F-14).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taylor Rezeppalead
- Ohio Universitycollaborator
Study Sites (1)
Ohio University
Athens, Ohio, 45705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine J. Forney, Ph.D.
Ohio University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctoral Candidate in Clinical Psychology
Study Record Dates
First Submitted
October 14, 2025
First Posted
October 20, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
October 20, 2025
Record last verified: 2025-10